The <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial

201285 citationsJournal Article

Authors

Treatment with OC000459 was well tolerated and led to a significant and persistent reduction in the symptoms of rhinoconjunctivitis.

Good health and well-being

Published in: Allergy

Volume 67, Issue 12, pp. 1572-1579

Field-Weighted Citation Impact: 5.22